286 related articles for article (PubMed ID: 24952696)
1. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience.
Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
[TBL] [Abstract][Full Text] [Related]
5. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
6. Persistent mild lesions in coronary angiography predict poor long-term survival of heart transplant recipients.
Zakliczynski M; Babinska A; Flak B; Nozynski J; Kamienska N; Szygula-Jurkiewicz B; Pacholewicz J; Przybylski R; Zembala M
J Heart Lung Transplant; 2014 Jun; 33(6):618-23. PubMed ID: 24388395
[TBL] [Abstract][Full Text] [Related]
7. Impact of Sex on Outcomes Among Patients With Cardiac Allograft Vasculopathy Who Undergo Percutaneous Coronary Intervention.
Lee MS; Wadia SK; Shlofmitz R
J Invasive Cardiol; 2020 Dec; 32(12):453-458. PubMed ID: 33221733
[TBL] [Abstract][Full Text] [Related]
8. Co-localization of Disturbed Flow Patterns and Occlusive Cardiac Allograft Vasculopathy Lesion Formation in Heart Transplant Patients.
Timmins LH; Gupta D; Corban MT; Molony DS; Oshinski JN; Samady H; Giddens DP
Cardiovasc Eng Technol; 2015 Mar; 6(1):25-35. PubMed ID: 26577100
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.
Xanthopoulou I; Davlouros P; Tsigkas G; Panagiotou A; Hahalis G; Alexopoulos D
Can J Cardiol; 2011; 27(6):716-24. PubMed ID: 22019279
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
12. Unprotected left main coronary artery percutaneous coronary intervention in a pediatric patient with cardiac allograft vasculopathy.
Tadwalkar RV; Lee MS
J Invasive Cardiol; 2014 Nov; 26(11):E156-60. PubMed ID: 25364007
[TBL] [Abstract][Full Text] [Related]
13. Re-stenosis after drug-eluting stents in cardiac allograft vasculopathy.
Aqel RA; Wells BJ; Hage FG; Tallaj J; Benza R; Pamboukian S; Rayburn B; McGiffin D; Kirklin J; Bourge R
J Heart Lung Transplant; 2008 Jun; 27(6):610-5. PubMed ID: 18503959
[TBL] [Abstract][Full Text] [Related]
14. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
[TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft vasculopathy.
Lee MS; Finch W; Weisz G; Kirtane AJ
Rev Cardiovasc Med; 2011; 12(3):143-52. PubMed ID: 22080925
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes.
Tarantini G; Favaretto E; Gardin A; Napodano M; Isabella G; Panfili M; Gerosa G; Iliceto S; Ramondo A
J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):396-402. PubMed ID: 18334895
[TBL] [Abstract][Full Text] [Related]
17. Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac
Shrestha UM; Sciammarella M; Pampaloni MH; Botvinick EH; Gullberg GT; DeMarco T; Seo Y
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1461-1472. PubMed ID: 33123937
[TBL] [Abstract][Full Text] [Related]
18. Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.
Zanchin C; Yamaji K; Rogge C; Lesche D; Zanchin T; Ueki Y; Windecker S; Mohacsi P; Räber L; Sigurdardottir V
PLoS One; 2018; 13(8):e0202950. PubMed ID: 30148864
[TBL] [Abstract][Full Text] [Related]
19. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
[TBL] [Abstract][Full Text] [Related]
20. Early aspirin use and the development of cardiac allograft vasculopathy.
Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
